跳至主要内容
临床试验/JPRN-UMIN000036497
JPRN-UMIN000036497已完成未知

Validation study of the efficacy of frailty discriminant score (FDS) in patients with urological cancers - Validation study of the efficacy of frailty discriminant score (FDS) in patients with urological cancers

Hirosaki Univ. School of Med.0 个研究点目标入组 559 人开始时间: 2019年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
559

研究概览

简要总结

The frailty discriminant score (FDS) is a reliable and valid tool for assessing frailty and prognosis in patients with urological cancers.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Key exclusion criteria: 1) patients with cancer except for PC, BC, UTUC, or RCC. 2) patients with severe general condition who could not evaluate the frailty using FDS. Controls (Ctrl)

研究者

发起方
Hirosaki Univ. School of Med.

相似试验